reference/32380138

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32380138

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, Non-P.H.S.
endingPage	1457
issn	0887-6924 1476-5551
issueIdentifier	6
pageRange	1453-1457
publicationName	Leukemia
startingPage	1453
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_448c3d7a8b95445db230c0de0b6d375a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1d169335b389e96c4db978feca345f0a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c7c984d489a562ecfe5bea96963f74f3 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f42648725aa536a067540eeab0d6e2e6
bibliographicCitation	Kobayashi M, Chen S, Bai Y, Yao C, Gao R, Sun XJ, Mu C, Twiggs TA, Yu ZH, Boswell HS, Yoder MC, Kapur R, Mulloy JC, Zhang ZY, Liu Y. Phosphatase PRL2 promotes AML1-ETO-induced acute myeloid leukemia. Leukemia. 2017 Jun;31(6):1453–7. PMID: 28220038; PMCID: PMC5695226.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2383835d63c083259583610d42726110 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2fe4da6fad41272fcab242ae3f39db31 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e042a4ed3c1f9c11c2b8ffb921f46839 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_082a43f337b80493b80132c85f7384bf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_386e9604c550b47ce4c0266a6a0f97af http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32cda836a793dd57671f88460323ad35 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5d10546a4f22b9834dd9cc8b72fd629 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b8919c05b166a9470c276117bf498aa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9be7f5f11d3c2a58e27ac46c9e6d4a94 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8149a4b3d6a01f132fb4352aee90b02e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13a2dfdf8b275b3daf68ecfbbd9acae7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6725e5d14c5ff07451e82d222515e1fa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8f57b8340e4306ddab7c4a8ab0f82ae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e52259b5733b956f357f8b509196f78 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20d0a9a386298a1e78b64f0fd0295b0f
date	2017-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/28220038 https://doi.org/10.1038/leu.2017.67 https://pubmed.ncbi.nlm.nih.gov/PMC5695226
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5536 https://portal.issn.org/resource/ISSN/1476-5551 https://portal.issn.org/resource/ISSN/0887-6924
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Phosphatase PRL2 promotes AML1-ETO-induced acute myeloid leukemia
discusses	http://id.nlm.nih.gov/mesh/M0280411 http://id.nlm.nih.gov/mesh/M0215816 http://id.nlm.nih.gov/mesh/M0468670 http://id.nlm.nih.gov/mesh/M0023875 http://id.nlm.nih.gov/mesh/M000629597 http://id.nlm.nih.gov/mesh/M0025868
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/11 http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103 http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a03cbeca561fb1c14c97da4488860cbe http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9731 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8836f3fdebca01ff8be835b2797e6a96 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_95ff6b3ae96d35114fc0d05cd50280c2

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8073

Total number of triples: 55.